2019 annual financial data

Sutro Biopharma 2019 Operating margin

Direct answer

Operating margin was -129.79%.

Operating income was -55.47M USD and net income was -55.74M USD.
Operating cash flow was -65.02M USD.

Get free Sutro Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
42.74M USD
Operating income
-55.47M USD
Net income
-55.74M USD
Operating cash flow
-65.02M USD